StonvexLoading…
StonvexStonvexStonvexCore line items from CTNM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|
Revenue | $0.00 | $50.00M |
Operating Income | $-50.89M | $16.08M |
Net Income | $-42.26M | $22.72M |
EPS (Diluted) | $-2.18 | $0.08 |
Total Assets | $212.85M | $130.39M |
Total Liabilities | $14.78M | $5.70M |
Cash & Equivalents | $21.94M | $15.53M |
Free Cash Flow OCF − CapEx | $-33.36M | $18.93M |
Shares Outstanding | 19.35M | 3.40M |